Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.
about
Structurally encoded intraclass differences in EphA clusters drive distinct cell responsesEphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion.CYCLOPS reveals human transcriptional rhythms in health and disease.Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcomaEphrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survivalEph receptor tyrosine kinases in cancer stem cellsDesign and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancerEPHA4 is overexpressed but not functionally active in Sézary syndrome.Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.EphA8 is a prognostic marker for epithelial ovarian cancer.EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancerLigand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.EphB6 overexpression and Apc mutation together promote colorectal cancer.Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor.Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?Eph family co-expression patterns define unique clusters predictive of cancer phenotype.JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.Transcriptome analysis of equine sarcoids.Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations-targeted resequencing study on formalin-fixed, paraffin-embedded tumor material of 81 patients.Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.[Advances on driver oncogenes of lung adenocarcinoma].Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo.Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.
P2860
Q27678839-62E49A42-A512-43A1-92D9-BE19FBE21516Q30539320-595D5260-77E1-453C-BE83-C1A341E77F05Q33719425-1FF582A9-1052-4C81-9F09-3CE4215BE32EQ33732473-98E9AC0D-A522-4932-B93E-8E6228EB2F92Q34524860-109A7124-FE32-4571-9E01-F6CF2F6DC32DQ34527304-74AD2332-6CB8-48EB-9F22-5562335757BFQ35889278-5B6091AA-FABA-49EF-B633-AE7DF0FAC0B7Q36035509-1014B208-9A80-4EC4-BBE8-8F6DA5E4229AQ36544714-656F7300-F45C-4F57-883E-908F3E16D961Q36765650-6BD340BA-E1EC-4E5F-A63C-0987A07BD79FQ36931136-BB377D16-3904-444C-BC3D-D1F67533CB10Q37190444-8CF2F65E-B355-4627-896A-D57CAF06EFB8Q37225289-9515F756-5F49-4E05-944F-67464DDDB105Q37312725-85B0848C-2913-40E4-A3DC-059E702AB0B8Q37327672-2B9111F0-BA38-4B4C-A444-85F505159701Q37635711-5E01621C-175A-46D6-A745-DE7D506E27C0Q38100162-719CE166-16D7-41E9-A200-2E7A84A91BC2Q38269791-FAAB4881-683A-4DDF-8E11-4B899D4F75D6Q39017426-D3D53613-6C3C-429A-ADF4-87D5C26D0F21Q39251476-E4B4E4CE-7707-4DE7-83BC-737E4DF785DFQ45907873-F249C2D5-538F-49C9-B3CD-94934A397F87Q50454825-68262793-F47F-4C04-85B5-CCB8C5AB9CEAQ53257774-2BCDDFB1-9CE7-48AF-8F23-7C4AC5F1FDB8Q54192833-F987D635-6C2B-41AD-994C-F3E93C86E03BQ55286883-7E6B01C8-5238-4C85-AC9E-326ED1D7226D
P2860
Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinical relevance of Ephs and ...... al, and lung cancer profiling.
@ast
Clinical relevance of Ephs and ...... al, and lung cancer profiling.
@en
type
label
Clinical relevance of Ephs and ...... al, and lung cancer profiling.
@ast
Clinical relevance of Ephs and ...... al, and lung cancer profiling.
@en
prefLabel
Clinical relevance of Ephs and ...... al, and lung cancer profiling.
@ast
Clinical relevance of Ephs and ...... al, and lung cancer profiling.
@en
P2860
P1476
Clinical relevance of Ephs and ...... al, and lung cancer profiling.
@en
P2093
Dana M Brantley-Sieders
P2860
P304
P356
10.1016/J.SEMCDB.2011.10.014
P577
2011-10-21T00:00:00Z